120 related articles for article (PubMed ID: 15618710)
1. Metabolic extraction of nifedipine during absorption from the rat small intestine.
Iwao T; Inoue K; Hayashi Y; Yuasa H; Watanabe J
Drug Metab Pharmacokinet; 2002; 17(6):546-53. PubMed ID: 15618710
[TBL] [Abstract][Full Text] [Related]
2. Absorption and metabolic extraction of diltiazem from the perfused rat small intestine.
Iwao T; Inoue K; Hayashi Y; Yuasa H; Watanabe J
Drug Metab Pharmacokinet; 2004 Dec; 19(6):430-7. PubMed ID: 15681897
[TBL] [Abstract][Full Text] [Related]
3. First-pass metabolism of 5-fluorouracil in the perfused rat small intestine.
Gu J; Yuasa H; Hayashi Y; Watanabe J
Biol Pharm Bull; 1998 Aug; 21(8):871-3. PubMed ID: 9743260
[TBL] [Abstract][Full Text] [Related]
4. Utilizing in vitro and PBPK tools to link ADME characteristics to plasma profiles: case example nifedipine immediate release formulation.
Wagner C; Thelen K; Willmann S; Selen A; Dressman JB
J Pharm Sci; 2013 Sep; 102(9):3205-19. PubMed ID: 23696038
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
[TBL] [Abstract][Full Text] [Related]
6. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human.
Emoto C; Yamazaki H; Iketaki H; Yamasaki S; Satoh T; Shimizu R; Suzuki S; Shimada N; Nakajima M; Yokoi T
Xenobiotica; 2001 May; 31(5):265-75. PubMed ID: 11491388
[TBL] [Abstract][Full Text] [Related]
7. Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine.
Kato R; Yuasa H; Inoue K; Iwao T; Tanaka K; Ooi K; Hayashi Y
Drug Metab Pharmacokinet; 2007 Apr; 22(2):96-102. PubMed ID: 17495416
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys.
Nishimuta H; Sato K; Mizuki Y; Yabuki M; Komuro S
Drug Metab Dispos; 2010 Nov; 38(11):1967-75. PubMed ID: 20702772
[TBL] [Abstract][Full Text] [Related]
9. The Disposition of Oxymatrine in the Vascularly Perfused Rat Intestine-Liver Preparation and Its Metabolism in Rat Liver Microsomes.
Huang LH; Zhong YM; Xiong XH; Cen MF; Cheng XG; Wang GX; Chen JS; Wang SJ
J Pharm Sci; 2016 Feb; 105(2):897-903. PubMed ID: 26869434
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir.
Koudriakova T; Iatsimirskaia E; Utkin I; Gangl E; Vouros P; Storozhuk E; Orza D; Marinina J; Gerber N
Drug Metab Dispos; 1998 Jun; 26(6):552-61. PubMed ID: 9616191
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats.
Higashikawa F; Murakami T; Kaneda T; Kato A; Takano M
J Pharm Pharmacol; 1999 Jan; 51(1):67-72. PubMed ID: 10197420
[TBL] [Abstract][Full Text] [Related]
12. Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat.
Li LY; Amidon GL; Kim JS; Heimbach T; Kesisoglou F; Topliss JT; Fleisher D
J Pharmacol Exp Ther; 2002 May; 301(2):586-93. PubMed ID: 11961060
[TBL] [Abstract][Full Text] [Related]
13. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
[TBL] [Abstract][Full Text] [Related]
14. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
15. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
16. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
James MO; Lou Z; Rowland-Faux L; Celander MC
Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes.
Emoto C; Yamazaki H; Yamasaki S; Shimada N; Nakajima M; Yokoi T
Xenobiotica; 2000 Oct; 30(10):943-53. PubMed ID: 11315103
[TBL] [Abstract][Full Text] [Related]
18. Intestinal first-pass metabolism of eperisone in the rat.
Mihara K; Matsumura M; Yoshioka E; Hanada K; Nakasa H; Ohmori S; Kitada M; Ogata H
Pharm Res; 2001 Aug; 18(8):1131-7. PubMed ID: 11587484
[TBL] [Abstract][Full Text] [Related]
19. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes.
Takemoto K; Yamazaki H; Tanaka Y; Nakajima M; Yokoi T
Xenobiotica; 2003 Jan; 33(1):43-55. PubMed ID: 12519693
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.
Martignoni M; Groothuis G; de Kanter R
Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
